Moreover, the IF results showed that there was the substantial nuclear aggregation of Nrf2 in AML cells in compared with normal cells, especially among relapse-refractory AML cells (P < 0.05, Fig. 1C, D). This evidence concerns the gene NFE2L2 and acute myeloid leukemia.